A synergistic effect between TET2 and RHOA G17V in inducing tumor cell proliferation was discovered in mouse models of AITL with TET2 deletion and RHOA G17V mutation (14, 37). This evidence concerns the gene RHOA and angioimmunoblastic T-cell lymphoma.